Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H12O2 |
Molecular Weight | 212.2439 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(OCC1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=SESFRYSPDFLNCH-UHFFFAOYSA-N
InChI=1S/C14H12O2/c15-14(13-9-5-2-6-10-13)16-11-12-7-3-1-4-8-12/h1-10H,11H2
Molecular Formula | C14H12O2 |
Molecular Weight | 212.2439 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://en.wikipedia.org/wiki/Benzyl_benzoate
http://www.drugbank.ca/drugs/DB00676
Curator's Comment: description was created based on several sources, including:
https://en.wikipedia.org/wiki/Benzyl_benzoate
http://www.drugbank.ca/drugs/DB00676
Benzyl benzoate is an organic compound with the formula C6H5CH2O2CC6H5. It is the ester of benzyl alcohol and benzoic acid. It forms either a viscous liquid or solid flakes and has a weak, sweet-balsamic odor. It occurs in a number of blossoms (e. g. tuberose, hyacinth) and is a component of Balsam of Peru and Tolu balsam. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. Benzyl benzoate is one of the older preparations used to treat scabies. Scabies is a skin infection caused by the mite sarcoptes scabiei. It is characterised by severe itching (particularly at night), red spots, and may lead to a secondary infection. Benzyl benzoate is lethal to this mite and so is useful in the treatment of scabies. It is also used to treat lice infestation of the head and body. Benzyl benzoate is not the treatment of choice for scabies due to its irritant properties. Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova, though its exact mechanism of action is unknown. In vitro, benzyl benzoate has been found to kill the Sarcoptes mite within 5 minutes.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | BRIGHTENING DYNAMICS TRAVELING KIT JAFRA Approved UseHelps prevent sunnburn. If used as directed, with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. |
|||
Curative | BENZYL BENZOATE Approved UseUnknown Launch Date1976 |
|||
Curative | BENZYL BENZOATE Approved UseUnknown Launch Date1976 |
Doses
Dose | Population | Adverse events |
---|---|---|
10 % 1 times / day multiple, topical Dose: 10 %, 1 times / day Route: topical Route: multiple Dose: 10 %, 1 times / day Sources: |
unhealthy, 4.7 years (range: 6 months - 15 years) n = 37 Health Status: unhealthy Condition: Scabies Age Group: 4.7 years (range: 6 months - 15 years) Population Size: 37 Sources: |
Other AEs: Localised skin reaction... |
25 % 1 times / day multiple, topical Dose: 25 %, 1 times / day Route: topical Route: multiple Dose: 25 %, 1 times / day Sources: |
pregnant, adult n = 444 Health Status: pregnant Condition: scabies Age Group: adult Sex: F Population Size: 444 Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Localised skin reaction | 12 patients | 10 % 1 times / day multiple, topical Dose: 10 %, 1 times / day Route: topical Route: multiple Dose: 10 %, 1 times / day Sources: |
unhealthy, 4.7 years (range: 6 months - 15 years) n = 37 Health Status: unhealthy Condition: Scabies Age Group: 4.7 years (range: 6 months - 15 years) Population Size: 37 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Gland cell cultures into 3D hyaluronan-based scaffolds. | 2003 Aug |
|
Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design. | 2003 Dec 31 |
|
The efficacy of benzyl benzoate sprays in killing the storage mite Tyrophagus putrescentiae (Acari: Acaridae). | 2004 |
|
Controlling scabies in institutional settings: a review of medications, treatment models, and implementation. | 2004 |
|
3 dimensional modelling of early human brain development using optical projection tomography. | 2004 Aug 6 |
|
In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability. | 2004 Dec 15 |
|
Design, synthesis, and photochemical behavior of poly(benzyl ester) dendrimers with azobenzene groups throughout their architecture. | 2004 Dec 24 |
|
Acaricidal activity of Paeonia suffruticosa root bark-derived compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae). | 2004 Dec 29 |
|
The clinical effect of environmental control of house dust mites in 60 house dust mite-sensitive dogs. | 2004 Feb |
|
Leaching of plasticizers from temporary denture soft lining materials. | 2004 Feb |
|
Inhibition of alpha-chymotrypsin with thiol-bearing substrate analogues in the presence of zinc ion. | 2004 Feb 9 |
|
[Reconstruction of extensive soft tissue loss by transplantation of dermal and epidermal equivalents]. | 2004 Jan |
|
[Nosocomial infection of scabies in national hospitals and sanatoria in Japan]. | 2004 Jul |
|
Phytochemistry and preliminary biological evaluation of Cyathostemma argenteum, a malaysian plant used traditionally for the treatment of breast cancer. | 2004 Jul |
|
Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: assessment of weight gain, liver function, nutrient digestibility, wool production and meat quality. | 2004 Mar |
|
Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: epidemiology; assessment of clinical, haematological, cell-mediated humoral immune responses and pathology. | 2004 Mar |
|
p-Anisaldehyde: acaricidal component of Pimpinella anisum seed oil against the house dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus. | 2004 Mar |
|
Controlled release of a model protein lysozyme from phase sensitive smart polymer systems. | 2004 Mar 1 |
|
Synthesis of [323]-p-octiphenyls: orthogonal functionalization along a rigid-rod scaffold for refined supramolecular architecture. | 2004 Mar 18 |
|
Genetic and molecular basis of grass cell-wall degradability. I. Lignin-cell wall matrix interactions. | 2004 May |
|
An evaluation of Hyalofill-F plus compression bandaging in the treatment of chronic venous ulcers. | 2004 May |
|
Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. | 2004 May |
|
Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae). | 2004 May 19 |
|
Rapid and sensitive quantitative analysis of alkyl phosphates in urine after organophosphate poisoning. | 2004 May-Jun |
|
Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. | 2004 Nov |
|
The transmediastinal arteries of the human testis: an anatomical study. | 2004 Oct |
|
Cytocompatibility and viscoelastic properties of phthalate ester-free tissue conditioners. | 2004 Sep |
|
Drug release from injectable depots: two different in vitro mechanisms. | 2004 Sep 30 |
|
Efficacy of various synthetic pyrethroid-impregnated encasement materials against house dust mite under laboratory conditions. | 2005 |
|
In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems. | 2005 |
|
Floral scent emission and pollinator attraction in two species of Gymnadenia (Orchidaceae). | 2005 Feb |
|
Immunobiological [correction of Immunobioloical] activity of a new benzyl benzoate from the aerial parts of Solidago virga-aurea var. gigantea. | 2005 Jan |
|
Structure formation in injectable poly(lactide-co-glycolide) depots. II. Nature of the gel. | 2005 Jan 15 |
|
Oligonucleotides conjugated to short lysine chains. | 2005 Jul-Aug |
|
Food protective effect of acaricidal components isolated from anise seeds against the stored food mite, Tyrophagus putrescentiae (Schrank). | 2005 Jun |
|
SAR studies of brasilicardin A for immunosuppressive and cytotoxic activities. | 2005 Mar 1 |
|
Acaricidal activity of active constituent isolated in Chamaecyparis obtusa leaves against Dermatophagoides spp. | 2005 Mar 23 |
|
Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation. | 2005 May 13 |
|
Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin. | 2005 May 2 |
|
In vitro release of insulin and biocompatibility of in situ forming gel systems. | 2005 Nov 4 |
|
Deazapurine solid-phase synthesis: combinatorial synthesis of a library of N3,N5,C6-trisubstituted pyrrolo[3,2-d]pyrimidine derivatives on cross-linked polystyrene bearing a cysteamine linker. | 2005 Nov-Dec |
|
Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants. | 2005 Nov-Dec |
|
Design of wide-spectrum inhibitors targeting coronavirus main proteases. | 2005 Oct |
|
Structure-activity studies of 3'-4'-dichloro-meperidine analogues at dopamine and serotonin transporters. | 2005 Oct 1 |
|
Pthiriasis capitis. | 2005 Sep |
|
Free radical generation during chemical depolymerization of heparin. | 2005 Sep 15 |
|
Crusted scabies in an adult T-cell leukemia/lymphoma patient successfully treated with oral ivermectin. | 2006 Feb |
|
Aluminum sulfate significantly reduces the skin test response to common allergens in sensitized patients. | 2006 Feb 14 |
|
Chemical-physical characterization and in vitro preliminary biological assessment of hyaluronic acid benzyl ester-hydroxyapatite composite. | 2006 Jan |
|
Acaricidal activities of paeonol and benzoic acid from Paeonia suffruticosa root bark and monoterpenoids against Tyrophagus putrescentiae (Acari: Acaridae). | 2006 Jun |
Patents
Sample Use Guides
30 mL of the lotion usually is sufficient for one application in adults and 20 mL usually is sufficient in children. The patient should bathe 24–48 hours after the last application to remove the drug.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10748911
no mites were alive after 3 h exposure to 25% benzyl benzoate (Ascabiol)
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:30 GMT 2023
by
admin
on
Fri Dec 15 15:13:30 GMT 2023
|
Record UNII |
N863NB338G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 172.515
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
||
|
WHO-ATC |
P03AX01
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
||
|
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION |
SCCS/1459/11
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
13.5
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
||
|
JECFA EVALUATION |
BENZYL BENZOATE
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
||
|
EPA PESTICIDE CODE |
9501
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
||
|
WHO-VATC |
QP53AX11
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB13023MIG
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
204-402-9
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
DTXSID8029153
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
m2400
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
8081
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
120-51-4
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
CHEMBL1239
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
benzyl benzoate
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
309
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
2345
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
208
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
N863NB338G
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
C65255
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
1062008
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
100000091327
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
C006723
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
41237
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
BENZYL BENZOATE
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | Description: A clear, colourless, oily liquid; odour, faintly aromatic. Miscibility: Practically immiscible with water and glycerol R; miscible with ethanol (~750 g/l) TS and ether R. Category: Scabicide (topical use). Storage: Benzyl benzoate should be kept in a tightly closed and well-filled container, protected from light. Additional information: Benzyl benzoate may slowly decompose on contact with air. Definition: Benzyl benzoate contains not less than 98.0% and not more than 100.5% of C14H12O2. | ||
|
335
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
BENZYL BENZOATE
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
19044
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB00676
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY | |||
|
N863NB338G
Created by
admin on Fri Dec 15 15:13:30 GMT 2023 , Edited by admin on Fri Dec 15 15:13:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT MAY BE PRESENT |
ASSAY (GC)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
http://apps.who.int/phint/pdf/b/Jb.6.1.51.pdf
|